This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Neurostimulation Industry

Overview III-1

Neurostimulation Products Market to Witness Growth III-1

Product Segments Ranked by Growth III-2

Table 28: Neurostimulation Market in the US (2010-2018):

Product Segments Ranked by Growth (Sales in US$

million)(includes corresponding Graph/Chart) III-2

Table 29: Neurostimulation Market in the US (2010-2018):Product Segments Ranked by Growth (Sales in Units)(includes corresponding Graph/Chart) III-3

Table 30: Neurostimulation Market in the US (2011): Unit

Sales & Percentage Breakdown by Product Segment - Spinal

Cord Stimulators (SCS), Deep Brain Stimulators (DBS),

Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators

(VNS) and Gastric Electric Stimulators (GES) (includes

corresponding Graph/Chart) III-3

Table 31: Neurostimulation Market in the US (2011): ValueSales (in US$ Million) & Percentage Market Share byProduct Segment - Spinal Cord Stimulators (SCS), DeepBrain Stimulators (DBS), Sacral Nerve Stimulators (SNS),Vagus Nerve Stimulators (VNS) and Gastric ElectricStimulators (GES) (includes corresponding Graph/Chart) III-4Potential Growth for Neurostimulation Systems in the US III-4Spinal Cord Stimulation Products Market III-5Table 32: US Spinal Cord Stimulator Market (2011):Percentage Share Breakdown by Company - Medtronic,St.Jude Medical Boston Scientific (includes correspondingGraph/Chart) III-5Sacral Nerve Stimulation Products Market III-5Deep Brain Stimulation Products Market III-6Shift Away from Orthopaedic and Cardiovascular Device Markets III-6Trends in the Embolotherapy Market III-7Neurovascular Stents Market Attracting Cardiovascular Companies III-8Migraine Devices - New Frontiers for Neurostimulation III-8Competitive Landscape III-8Table 33: Leading Players in the US NeurostimulationMarket (2011): Percentage Breakdown of Revenues forMedtronic, Advanced Bionics, St. Jude Medical, Cyberonicsand Others (includes corresponding Graph/Chart) III-9Neurostimulation Device Approvals III-9Recent Industry Activity III-13Product Innovations/ Introductions III-17Key Players III-19B.Market Analytics III-22Table 34: US Recent Past, Current & Future Analysis forNeurostimulators by Product Segment - Spinal CordStimulators (SCS), Deep Brain Stimulators (DBS), SacralNerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), andGastric Electric Stimulators (GES) Markets IndependentlyAnalyzed with Annual Sales Figures in Units for Years 2010through 2018 (includes corresponding Graph/Chart) III-22

Table 35: US Recent Past, Current & Future Analysis for

Neurostimulators by Product Segment - Spinal Cord

8 of 11

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs